Get In Touch

Investor Relations

Investment Opportunities

GlobeStar Therapeutics Corporation (OTCQB: GSTC), formerly AngioSoma, is a growth-minded company working in the field of neurodegenerative disease.

The prior version of our investor deck can be found below.

Information Sources

GlobeStar is a publicly traded clinical stage biotechnology company with the OTCBB ticker symbol GSTC. The company has a patented formulation of currently available drugs which have been shown, in our formulation, to enhance the quality of life for Multiple Sclerosis patients.

GlobeStar does not provide forward-looking information and will consistently update our website as appropriate. If you would like to reach out to our investor relations department, please contact us below or email info@globestarthera.com

Transfer Agent

Standard Registrar and Transfer Company

440 East 400 South, Suite 200
Salt Lake City, UT 84111

Phone:
(801) 571-8844 or (801) 596-2150

Legal Counsel

Sonfield & Sonfield,
Attorneys at Law

(Information on OTC Markets)

2500 Wilcrest Drive, Suite 300
Houston, TX 77042

Accountants

M&K CPAS, PLLC
(Information on OTC Markets)

4100 North Sam Houston Pkwy W,
Suite 200-B, Houston, TX 77086
(832) 242-9950